Royalty Pharma buys BeOne stake in Amgen lung cancer drug sales
Written by
BioPharma Dive
Published
0
comments
0
min
An $885M deal with BeOne Medicine gives the pharma financier rights to a revenue stream from global sales of Imdelltra, which is sold by Amgen.